the correction factor, it may be more appropriate to express the FLC results in an arbitrary way, such as Freelite™ units per liter rather than absolute concentration units (i.e., milligrams per liter).
Simulating Total Error While Excluding Results Underestimates Total Error

To the Editor:
Karon et al. (1 ) modeled the effects of glucose meter error on insulin dosing errors. They refer to an earlier model that I had pointed out was incomplete (2 ) . Although Boyd and Bruns (3 ) agreed with my assessment, the current simulation is, once again, incomplete and the same as the previous simulation.
We have reviewed the statistics for glucose meter performance (4 ) and noted that Lawton and coworkers (5 ) have a simple and complete model for analytical assay error:
where %TE is the percent total error, %Bias is the percent mean bias, CV T is the total CV due to imprecision, CV RI is the total CV due to random patient interferences, and f is a factor to contain a percentage of the results (e.g., 1.95 would contain Ϯ95% of the results).
The model of Karon et al. leaves off the f ⅐ (CV RI ) term. It is difficult to understand why these authors did not use the model of Lawton et al., because they acknowledged problems due to interferences when they stated, "patients in the intensive care unit (ICU) are on multiple medications and often have abnormal hematocrit and/or oxygen tension, all of which may affect the performance of handheld glucose meters" (1 ) .
Their modeling is incomplete in another way. They use an f value of 1.65, which is presumably a 1-sided factor to contain 95% of the results. This value leaves 5% of the results as Ͼ2 ⅐ CV T and not part of the authors' considerations for the insulin dosing error. At just the one institution in the study, this value would amount to 2992 unspecified glucose results per year, and because these results are Ͼ2 ⅐ CV T , they are likely to cause insulin dosing errors. If specifications for tight glycemic control were applied to the general population of 7.2 million glucose meter users in the US, then on the basis of 1 test per day, there would be 131 ϫ 10 6 unspecified glucose results per year.
In addition to the analytical error, user error should also be included in the simulation. The goal of any simulation is to faithfully describe what happens in the real world, and user error contributes to the total error.
The authors mention that "error simulation modeling may not reflect sources of bias . . . , such as hematocrit effect, operator error, or bias introduced by sample type (capillary vs venous vs arterial) that may compound the errors modeled in this study and thus demand that meter error tolerances be more stringent than those defined here" (1 ). I would argue that, rather than "error" simulation modeling, it is their simulation modeling that does not reflect these biases. The modeling could certainly be amended to reflect these biases and provide a better rationale for meter error tolerances. 
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In Reply
Krouwer is correct that our recent modeling study did not integrate quantitative estimates of the contributions of random patient interferences. As Boyd and Bruns noted earlier in addressing a similar criticism of their 2001 simulation modeling study, it is difficult to know how one might model such interferences in a meaningful way (1 ) . We are unaware of published data regarding the magnitudes or frequencies of all random patient interferences that might affect glucose measurements by meters, and we chose therefore to bring up the effects of such interferences in a nonquantitative fashion in the discussion of our report. As we pointed out, such interferences will only increase the total error of glucose meter measurements, leading to the elaboration of even more stringent criteria regarding allowable analytical performance specifications for meters. The 1.65 multiplier used in our modeling scheme is one traditionally applied in total-error modeling studies of laboratory analytical quality (2 ) . We used it as a matter of convention. Other larger multipliers that exclude fewer observations in the tails of the distribution certainly can be used for modeling and will proportionately narrow the allowable assay CVs to meet a given total error requirement.
